Company Filing History:
2 out of 902 
1 out of 893 
Years Active: 2020-2023
Title: Kevin Urak: Innovator in Nucleic Acid Aptamers
Introduction
Kevin Urak is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid aptamers. With a total of 2 patents, his work focuses on innovative methods to treat histone-induced disease states.
Latest Patents
Kevin Urak's latest patents include groundbreaking inventions related to nucleic acid aptamers designed to treat histone-induced disease states. The first patent details optimized aptamers and methods for their use. The second patent outlines methods for treating subjects with histone-induced injuries or diseases by administering a pharmaceutical composition that includes specific nucleic acid molecules targeting extracellular histones. These aptamers are crucial in advancing therapeutic options for patients affected by such conditions.
Career Highlights
Throughout his career, Kevin has worked with esteemed organizations, including the University of Iowa Research Foundation and the United States Government as represented by the Department of Veterans Affairs. His experience in these institutions has allowed him to contribute to significant advancements in medical research and treatment methodologies.
Collaborations
Kevin has collaborated with notable colleagues such as Paloma H Giangrande and Francis G Miller. These partnerships have further enriched his research and development efforts in the field of nucleic acid aptamers.
Conclusion
Kevin Urak's innovative work in the development of nucleic acid aptamers represents a significant advancement in the treatment of histone-induced diseases. His contributions continue to impact the field of biotechnology positively.